These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 17854599

  • 1. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
    Gracia-Sancho J, Laviña B, Rodríguez-Vilarrupla A, Brandes RP, Fernández M, Bosch J, García-Pagán JC.
    Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
    [Abstract] [Full Text] [Related]

  • 2. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B, Gracia-Sancho J, Rodríguez-Vilarrupla A, Chu Y, Heistad DD, Bosch J, García-Pagán JC.
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [Abstract] [Full Text] [Related]

  • 3. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T, Steinbach AC, Steffen A, Rettig R, Grisk O.
    Cardiovasc Res; 2008 Nov 01; 80(2):271-9. PubMed ID: 18596059
    [Abstract] [Full Text] [Related]

  • 4. Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
    Rodríguez-Vilarrupla A, Graupera M, Matei V, Bataller R, Abraldes JG, Bosch J, García-Pagán JC.
    Liver Int; 2008 Apr 01; 28(4):566-73. PubMed ID: 18339082
    [Abstract] [Full Text] [Related]

  • 5. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    García-Calderó H, Rodríguez-Vilarrupla A, Gracia-Sancho J, Diví M, Laviña B, Bosch J, García-Pagán JC.
    J Hepatol; 2011 Apr 01; 54(4):660-5. PubMed ID: 21159403
    [Abstract] [Full Text] [Related]

  • 6. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
    Abraldes JG, Rodríguez-Vilarrupla A, Graupera M, Zafra C, García-Calderó H, García-Pagán JC, Bosch J.
    J Hepatol; 2007 Jun 01; 46(6):1040-6. PubMed ID: 17335931
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M, Diví M, Rodríguez-Vilarrupla A, Rosado E, Gracia-Sancho J, Vilaseca M, Bosch J, García-Pagán JC.
    J Hepatol; 2013 May 01; 58(5):904-10. PubMed ID: 23262250
    [Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
    Belin de Chantemèle EJ, Vessières E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D.
    Cardiovasc Res; 2009 Mar 01; 81(4):788-96. PubMed ID: 19050009
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
    Graupera M, García-Pagán JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, Rodés J.
    Hepatology; 2003 Jan 01; 37(1):172-81. PubMed ID: 12500202
    [Abstract] [Full Text] [Related]

  • 10. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
    Graupera M, March S, Engel P, Rodés J, Bosch J, García-Pagán JC.
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr 01; 288(4):G763-70. PubMed ID: 15550559
    [Abstract] [Full Text] [Related]

  • 11. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
    Edirimanne VE, Woo CW, Siow YL, Pierce GN, Xie JY, O K.
    Can J Physiol Pharmacol; 2007 Dec 01; 85(12):1236-47. PubMed ID: 18066125
    [Abstract] [Full Text] [Related]

  • 12. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F.
    Gastroenterology; 2007 Feb 01; 132(2):709-19. PubMed ID: 17258737
    [Abstract] [Full Text] [Related]

  • 13. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
    Vera R, Sánchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Pérez-Vizcaíno F, Duarte J.
    Clin Sci (Lond); 2007 Feb 01; 112(3):183-91. PubMed ID: 17007611
    [Abstract] [Full Text] [Related]

  • 14. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ, Qiu JF, Luo M, Sun YW, Zhao G, Chen W, Liu H, Wu ZY.
    J Gastroenterol Hepatol; 2008 Aug 01; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.
    Gupta TK, Toruner M, Chung MK, Groszmann RJ.
    Hepatology; 1998 Oct 01; 28(4):926-31. PubMed ID: 9755227
    [Abstract] [Full Text] [Related]

  • 16. Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production.
    Kassan M, Lasker GF, Sikka SC, Mandava SH, Gokce A, Matrougui K, Hellstrom WJ, Kadowitz PJ, Serefoglu EC.
    Urology; 2013 Nov 01; 82(5):1188.e1-7. PubMed ID: 24242893
    [Abstract] [Full Text] [Related]

  • 17. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
    Oelze M, Warnholtz A, Faulhaber J, Wenzel P, Kleschyov AL, Coldewey M, Hink U, Pongs O, Fleming I, Wassmann S, Meinertz T, Ehmke H, Daiber A, Münzel T.
    Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1753-9. PubMed ID: 16763163
    [Abstract] [Full Text] [Related]

  • 18. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
    Matei V, Rodríguez-Vilarrupla A, Deulofeu R, Colomer D, Fernández M, Bosch J, Garcia-Pagán JC.
    Hepatology; 2006 Jul 01; 44(1):44-52. PubMed ID: 16799985
    [Abstract] [Full Text] [Related]

  • 19. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
    Chan EC, Datla SR, Dilley R, Hickey H, Drummond GR, Dusting GJ.
    Cardiovasc Res; 2007 Sep 01; 75(4):710-8. PubMed ID: 17659266
    [Abstract] [Full Text] [Related]

  • 20. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E, Rodríguez-Vilarrupla A, Gracia-Sancho J, Tripathi D, García-Calderó H, Bosch J, García-Pagán JC.
    Hepatology; 2013 Oct 01; 58(4):1424-35. PubMed ID: 23703868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.